4 Sep 2017 07:00
Instem plc
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will announce half year results for the six months ended 30 June 2017 on Tuesday 26th September 2017.
Management will be hosting a presentation for analysts on the day of the results at 9.30am. Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.
For further information, please contact:
Instem plc | +44 (0) 1785 825 600 |
Phil Reason, CEO Nigel Goldsmith, CFO
|
|
N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
Richard Lindley Nick Owen
|
|
Walbrook Financial PR | +44 (0) 20 7933 8000 |
Paul Cornelius Helen Cresswell Sam Allen | instem@walbrookpr.com |
About Instem
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit www.instem.com